Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2007
06/13/2007EP1794115A2 N-ethyl hydroxyethylamines useful in treating cns conditions
06/13/2007EP1794114A1 N-methyl hydroxyethylamine useful in treating cns conditions
06/13/2007EP1793870A2 Odour-reducing quinone compounds
06/13/2007EP1793856A2 Methods and compositions for treating allergic inflammation
06/13/2007EP1793854A1 Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor
06/13/2007EP1793846A1 Compositions and methods comprising vitamin b12 and an impdh inhibitor for treating viral, inflammatory and proliferative diseases
06/13/2007EP1793843A1 Macrocyclic sh2 domain binding inhibitors
06/13/2007EP1793842A2 Treatment for cancer-related fatigue
06/13/2007EP1793838A2 Amphiphilic polynorbornene derivatives and methods of using the same
06/13/2007EP1793837A2 Fatty acid modified polylysines as antimicrobial agents
06/13/2007EP1793836A2 Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same
06/13/2007EP1793835A2 SMALL INTERFERING RNAs THAT EFFICIENTLY INHIBIT VIRAL GENE EXPRESSION AND METHODS OF USE THEREOF
06/13/2007EP1793834A1 Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof
06/13/2007EP1793833A1 Multiple sclerosis treatment
06/13/2007EP1793832A2 Geranylgeranyl pyrophosphate synthase inhibitors
06/13/2007EP1793831A2 Method of treatment for or protection against lymphedema
06/13/2007EP1793830A2 Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor
06/13/2007EP1793829A1 Use of pharmaceutical compositions of lofepramine for the treatment of adhd, cfs, fm and depression
06/13/2007EP1793828A2 Fibrate compounds having ppar agonist activity
06/13/2007EP1793827A2 Tricyclic anilide spirolactam cgrp receptor antagonists
06/13/2007EP1793826A2 Chemical compounds
06/13/2007EP1793825A2 Chemcial compounds
06/13/2007EP1793824A1 New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders
06/13/2007EP1793823A2 Sulfonyl hydrazines as hypoxia-selective antineoplastic agents
06/13/2007EP1793822A1 Tricycles, their manufacture and use as pharmaceutical agents
06/13/2007EP1793821A2 Pyrazolone compounds for treating cerebrovascular disorders
06/13/2007EP1793820A2 Ligand-dependant activation of nur77 and uses thereof
06/13/2007EP1793819A2 Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus
06/13/2007EP1793818A2 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
06/13/2007EP1793817A2 Methods of treating a disorder
06/13/2007EP1793816A2 Compositions for treating amyloid associated diseases
06/13/2007EP1793815A2 Amorphous atorvastatin calcium
06/13/2007EP1793814A2 Thyroid hormone analogs for promoting angiogenesis
06/13/2007EP1793813A2 Treatment of adhd
06/13/2007EP1793812A2 Antibiotic compound
06/13/2007EP1793809A2 Modified release ibuprofen dosage form
06/13/2007EP1793808A1 Solid unit dosage forms of 5-ht1 agonist
06/13/2007EP1793805A1 Liposomal formulations comprising an amphipathic weak base like tempamine for treatment of neurodegenerative conditions
06/13/2007EP1793804A2 Use of liposomal glucocorticoids for treating inflammatory states
06/13/2007EP1793803A2 Conveniently implantable sustained release drug compositions
06/13/2007EP1793802A1 Controlled and directed local delivery of anti-inflammatory compositions
06/13/2007EP1793801A1 Novel granulation process and granulate produced therefrom
06/13/2007EP1793793A1 An antioxidant complex and a cosmetic and pharmaceutical composition comprising said complex
06/13/2007EP1793675A2 Salts of decitabine
06/13/2007EP1793673A1 Cyclodextrin inclusion complexes and methods of preparing same
06/13/2007EP1793671A2 Use of memantine (namenda) to treat autism, compulsivity, and impulsivity
06/13/2007EP1641784B1 4-(aminomethyl)-piperidine benzamides as 5ht4 -antagonists
06/13/2007EP1636213B1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
06/13/2007EP1611122B1 Substituted pyrazole compounds
06/13/2007EP1534709B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
06/13/2007EP1532139B1 Total synthesis of myriaporones
06/13/2007EP1519908B1 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
06/13/2007EP1499623B1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-¬(2-methyl-1h-imidazol-1-yl)methyl|-4h-carbazol-4-one
06/13/2007EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
06/13/2007EP1487840B1 Crystalline polymorphic form of irinotecan hydrochloride
06/13/2007EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist
06/13/2007EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof
06/13/2007EP1448456B1 Transdermal/transmucosal patch packaging
06/13/2007EP1444247B1 Tibolone formulations
06/13/2007EP1437353B1 Alkyl ether derivatives or salts thereof
06/13/2007EP1416931B1 Inhibitors of polyq-aggregation
06/13/2007EP1408988B1 Compositions of orally administered nutritional supplements to repair articular cartilage
06/13/2007EP1387844B1 Retinol derivatives potentiation of active substances by micellar preparation
06/13/2007EP1385552B1 Oral delivery method and composition for solid medications or dietary supplements
06/13/2007EP1381352B1 Transdermal patch for administering fentanyl
06/13/2007EP1363932B1 Amphoteric sterols and the use thereof
06/13/2007EP1357944B1 Perylenequinones for use with immunotherapy agents
06/13/2007EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2007EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
06/13/2007EP1335926B1 Method of separating extra-chromosomal dna from other cellular components
06/13/2007EP1330425B1 C-nitroso compounds and use thereof
06/13/2007EP1326611B1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
06/13/2007EP1320383B1 Photosensitisers
06/13/2007EP1299358B1 Pyridoxine and pyridoxal analogues as cardiovascular therapeutics
06/13/2007EP1292305B1 Use of l-threo methylphenidate for the manufacture of a medicament for the treatment of psychotic disorders
06/13/2007EP1276474B1 Formulations for use in inhaler devices
06/13/2007EP1276469B1 Taste masking coating composition
06/13/2007EP1267925B1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
06/13/2007EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof
06/13/2007EP1214292B1 Tyrosine derivatives
06/13/2007EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor
06/13/2007EP1171104B1 Transdermal therapeutic system with neutralized acrylic adhesive patch
06/13/2007EP1142575B1 Dry skin remedies
06/13/2007EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof
06/13/2007EP1100895B1 Abc1 polypeptide and methods and reagents for modulating cholesterol levels
06/13/2007EP1083177B1 Compounds capable of cleaving double-stranded dna and method of utilization of the same
06/13/2007EP1069914B1 Controlled release tablet produced from linear water-insoluble polysaccharides
06/13/2007EP1069909B1 Conjugate vaccines for the prevention of dental caries
06/13/2007EP1027429B1 Jnk3 modulators and methods of use
06/13/2007EP1000040B1 Il-5 inhibiting 6-azauracil derivatives
06/13/2007EP0986572B2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
06/13/2007EP0954330B1 Intestinal trefoil proteins
06/13/2007EP0889972B1 Use of the determination of polymorphims in the promoter region of the TGF-beta 1 gene in diagnosis
06/13/2007EP0862630B1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/13/2007EP0792278B1 Tumor necrosis factor-gamma
06/13/2007EP0777486B2 Allergy-protective formula food with gangliosides
06/13/2007CN1981044A Lipid encapsulated interfering RNA
06/13/2007CN1980974A Low molecular weight polymers
06/13/2007CN1980949A New 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17beta-hydroxy steroid dehydrogenase type 1
06/13/2007CN1980946A Method for preparing A1 adenosine receptor agonists
1 ... 3715 3716 3717 3718 3719 3720 3721 3722 3723 3724 3725 3726 3727 3728 3729 3730 3731 3732 3733 3734 3735 ... 7860